|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Revenue from contracts with customers | ||
| Cost of care delivery | ||
| Revenue | ||
| Claims expense | ||
| Clinical care delivery expense | ||
| Platform & application expenses | ||
| Operating loss | ||
| Finance costs | ||
| Finance income | ||
| Change in fair value of warrant liabilities | ||
| Exchange gain / (loss) | ||
| Net finance income (expense) | ||
| Gain on remeasurement of equity interest | ||
| Share of loss of equity-accounted investees | ||
| Loss before taxation | ||
| Net loss attributable to ordinary shareholders | ||
| Comprehensive income, attributable to owners of parent | ||
| Comprehensive income, attributable to non-controlling interests | ||
| Currency translation differences | ||
| Other comprehensive gain / (loss) for the year, net of income tax | ||
| Total comprehensive loss for the year | ||
| Net loss per share, Basic and Diluted (in usd per share) | ||
| Weighted average shares outstanding, Basic and Diluted (in shares) | ||
| Equity holders of the parent | ||
| Non-controlling interest | ||
| Research & development expenses | ||
| Sales, general & administrative expenses | ||
| Premium deficiency reserve income / (expense) | ||
| Impairment expense | ||
| Depreciation and amortization expenses | ||
| Loss from operations | ||
| Interest expense | ||
| Interest income | ||
| Gain on fair value remeasurement | ||
| Loss on settlement of warrants | ||
| Exchange (loss) / gain | ||
| Gain on sale of subsidiary | ||
| Share of net loss on equity method investments | ||
| Net loss from operations before income taxes | ||
| Tax benefit / (provision) | ||
| Net loss | ||
| Total comprehensive loss attributable to: | ||
| Equity holders of the parent | ||
| Non-controlling interest | ||
| Other comprehensive loss | ||
| Currency translation differences | ||
| Other comprehensive gain / (loss), net of income tax | ||
| Total comprehensive loss | ||
| Net loss per share | ||
| Net loss per share, basic, from continuing operations (in dollars per share) | ||
| Net loss per share, diluted, from continuing operations (in dollars per share) | ||
| Weighted average shares outstanding, basic (in shares) | ||
| Weighted average shares outstanding, diluted (in shares) |
Loading...
